Leapmotor (SEHK:9863) has introduced the D19, described as the world's first premium SUV using a centralized QNX based software platform.
The system integrates the digital cockpit, advanced driver assistance, and connectivity functions into a single safety certified domain.
This launch marks the first mass produced vehicle to consolidate these core software defined features on advanced QNX platforms.
For investors watching the electric vehicle space, this move puts software architecture at...
Sinopharm Group (SEHK:1099) opened 2026 with Q1 revenue of about CNY 17.8b and basic EPS of CNY 0.52, setting the tone against a trailing twelve month profile that shows revenue of roughly CNY 574.7b and EPS of CNY 2.28. Over recent quarters investors have seen quarterly revenue move from about CNY 141.7b in Q1 2025 to CNY 145.4b in Q3 2025 and CNY 143.7b in Q4 2025, with basic EPS ranging from CNY 0.47 to CNY 3.29 across that period as the business cycled through different earnings levels...
If you are looking at Cathay Pacific Airways and asking whether the current share price fairly reflects its prospects, the valuation story is where things get interesting.
The stock last closed at HK$11.96, with returns of 1.2% over 7 days, a 0.5% decline over 30 days, a 5.3% decline year to date, 43.4% over 1 year, 90.9% over 3 years and 108.7% over 5 years. This performance may lead you to question whether the current price still offers value or has already priced in much of the recent...
Genscript Biotech (SEHK:1548) has proposed amendments to its memorandum and articles of association.
The planned changes relate to the company’s core corporate governance framework and could influence shareholder rights and internal decision making.
For investors watching Genscript Biotech at a share price of HK$14.19, the move to adjust its foundational documents comes alongside mixed longer term share performance. The stock is up 6.6% over the past week, 33.9% over the past month, 10.9%...
At its annual general meeting held on May 7, 2026, Ubtech Robotics Corp. Ltd. approved an H share repurchase that will cancel shares, reduce the company’s registered capital, and require amendments to its Articles of Association and related regulatory filings.
This move is significant because it combines a capital structure change with formal bylaw revisions, prompting creditor notifications and potential bondholder meetings under applicable regulations.
We’ll now examine how the approved H...
If you are wondering whether Akeso shares still offer value after a strong run, the numbers behind the current price deserve a closer look.
At a last close of HK$149.30, Akeso has delivered returns of 1.3% over 7 days, 33.2% over 30 days, 31.8% year to date and 60.7% over 1 year, with a very large 3 year gain and 173.2% over 5 years.
These moves have put Akeso on the radar of investors trying to understand what is already priced in and what may still be up for grabs. Recent coverage has...
Global markets have recently experienced a positive shift, with U.S. stocks achieving record highs and European indices showing strong performance, driven by easing geopolitical tensions and favorable economic data. In this context, penny stocks—often representing smaller or newer companies—continue to capture investor interest as they present unique opportunities for growth at lower price points. Despite the term 'penny stock' being somewhat outdated, these investments can still offer...
As global markets experience a positive shift with signs of de-escalation in the Middle East and strong earnings reports, investor sentiment is buoyed across major indices. In this context, penny stocks—often representing smaller or less-established companies—remain an intriguing investment area due to their potential for significant value growth. While the term may seem outdated, these stocks can offer opportunities for growth when backed by solid financials and a clear trajectory, making...
Grand Pharmaceutical Group (SEHK:512) just reported that its DOORwaY90 trial for SIR-Spheres Y-90 in unresectable hepatocellular carcinoma met its clinical endpoint, a key data point for investors watching its radiopharmaceutical pipeline.
See our latest analysis for Grand Pharmaceutical Group.
The DOORwaY90 success comes at a time when Grand Pharmaceutical Group’s short-term share price performance has been weak, with a 30-day share price return showing a decline of 5.35% and a 90-day share...
As of April 2026, Asian markets are navigating a complex landscape shaped by geopolitical developments and mixed economic signals. Amidst this backdrop, the allure of penny stocks remains significant for investors seeking opportunities in smaller or newer companies that may offer value and growth potential. While the term "penny stocks" might seem outdated, these investments can still be relevant when backed by solid financials, offering a unique combination of affordability and potential...
If you are wondering whether Air China is priced attractively today, the focus here is on what the current share price might be telling you about its underlying value.
The stock last closed at HK$5.23, with returns of 8.1% over the past week, 3.8% over the past month, 9.2% over the past year and a year-to-date decline of 26.4%, which may shape how you think about both opportunity and risk.
Recent coverage around Air China has centred on its role in the broader airline sector, including how...
Quarterly sales update and why it matters for ANTA Sports Products
ANTA Sports Products (SEHK:2020) reported first quarter 2026 retail sales, with ANTA branded products posting high single digit growth, FILA in the low teens, and other brands advancing by about 40% to 45% versus 2025.
This mix highlights how the group’s multi brand model is working across its portfolio, and it gives you a fresh data point on how core and emerging labels are each contributing to overall retail performance.
See...
As Asian markets navigate a landscape marked by geopolitical tensions and economic fluctuations, investors are increasingly focused on identifying opportunities that may be undervalued relative to their intrinsic value. In this context, understanding the fundamentals of a company and its potential for growth is crucial for discerning stocks that might offer attractive valuations amidst broader market conditions.
As global markets show positive sentiment amid geopolitical de-escalation and robust economic indicators, Asia's financial landscape is also experiencing significant developments. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.
Global markets have been buoyed by positive geopolitical developments, with U.S. stocks reaching new highs amid de-escalating Middle East tensions and strong earnings reports. In this context, penny stocks—often smaller or newer companies—remain a relevant investment area despite the term's outdated feel. These stocks can offer growth potential at lower price points, especially when backed by solid financials, providing investors an opportunity to uncover hidden value amidst current market...
361 Degrees International (SEHK:1361) reported its first quarter 2026 sales update, with core and kids branded products each posting around 10% year over year retail sales growth, while e commerce retail sales delivered mid double digit growth.
See our latest analysis for 361 Degrees International.
The sales update appears to have come alongside building momentum in the shares, with a 30.22% 1 month share price return and 29.74% year to date share price return, contributing to a 208.39% 5...
If you are wondering whether COSCO SHIPPING Holdings at HK$14.70 still offers value, you are not alone. The recent share performance has put its pricing firmly in the spotlight for many investors.
The stock has seen a 4.8% decline over the last 7 days and a 7.8% decline over the last 30 days. Year to date it is up 5.8%, the 1 year return sits at 48.1%, the 3 year return is 143.6%, and the 5 year return is 217.2%.
These moves sit against a backdrop of ongoing attention on global shipping...
TCL Electronics Holdings recently announced the RM9L RGB‑Mini LED TV series, its most advanced RGB–Mini LED lineup to date, featuring up to 6,000 peak nits, more than 3,800 local dimming zones, Dolby Vision 2 Max support, and Bang & Olufsen audio across 85", 98", and 115" models priced at US$7,999.99, US$9,999.99, and US$29,999.99 respectively.
This move signals TCL’s push deeper into the premium large‑screen TV segment by pairing its RGB–Mini LED and CSOT panel technology with high‑end...
